retatrutide triple hormone receptor agonist retatrutide Media Centre | EASD

If youve ever started a GLP-1 regimen and felt the same, youre not alone

8 weeks (11 vials): 33 mL 4 10 mL bottles 12 weeks (17 vials): 51 mL 6 10 mL bottles 16 weeks (22 vials): 66 mL 7 10 mL bottles Alcohol Swabs: One for the vial stopper + one for the injection site each day

Eli Lilly and Company Lilly's triple agonist, retatrutide, demonstrated significant reductions in A1C and weight in first Phase 3 trial for treatment of type 2 diabetes

Im optimistic on how the combination of an oral option plus market competition is going to mean access for more patients that want and would benefit from these medications

Step 4: Make duplicates of your document - it will help you stay clear of upcoming worries

To view or add a comment, sign in Explore related topics Explore content categories